210 related articles for article (PubMed ID: 1955398)
1. Anthracycline metabolites from Streptomyces violaceus A262. V. New anthracycline alldimycin A: a minor component isolated from obelmycin beer.
Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1160-4. PubMed ID: 1955398
[No Abstract] [Full Text] [Related]
2. Anthracycline metabolites from Streptomyces violaceus A262. IV. New anthracycline yellamycins produced by a variant strain SC-7.
Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1155-9. PubMed ID: 1955397
[No Abstract] [Full Text] [Related]
3. Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730.
Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1121-9. PubMed ID: 1955395
[TBL] [Abstract][Full Text] [Related]
4. Anthracycline metabolites from Streptomyces violaceus A262. III. New anthracycline obelmycins produced by a variant strain SE2-2385.
Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1130-40. PubMed ID: 1955396
[TBL] [Abstract][Full Text] [Related]
5. Isolation of new anthracyclines 10-O-rhodosaminyl beta-rhodomycinone and beta-isorhodomycinone from mild-acid treated culture of obelmycin-producing Streptomyces violaceus.
Johdo O; Yoshioka T; Takeuchi T; Yoshimoto A
J Antibiot (Tokyo); 1997 Jun; 50(6):522-5. PubMed ID: 9268010
[No Abstract] [Full Text] [Related]
6. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. II. New anthracycline metabolites produced by a blocked mutant strain RPM-5.
Yoshimoto A; Fujii S; Johdo O; Kubo K; Nishida H; Okamoto R; Takeuchi T
J Antibiot (Tokyo); 1993 Jan; 46(1):56-64. PubMed ID: 8436560
[TBL] [Abstract][Full Text] [Related]
7. Anthracycline metabolites from Streptomyces violaceus A262. I. Isolation of antibiotic-blocked mutants from Streptomyces violaceus A262.
Johdo O; Ishikura T; Yoshimoto A; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1110-20. PubMed ID: 1955394
[TBL] [Abstract][Full Text] [Related]
8. Demethyl mutactimycins, new anthracycline antibiotics from Nocardia and Streptomyces strains.
Speitling M; Nattewan P; Yazawa K; Mikami Y; Grün-Wollny I; Ritzau M; Laatsch H; Gräfe U
J Antibiot (Tokyo); 1998 Aug; 51(8):693-8. PubMed ID: 9766460
[TBL] [Abstract][Full Text] [Related]
9. Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity.
Sugawara K; Hatori M; Nishiyama Y; Tomita K; Kamei H; Konishi M; Oki T
J Antibiot (Tokyo); 1990 Jan; 43(1):8-18. PubMed ID: 2106503
[TBL] [Abstract][Full Text] [Related]
10. New rhodomycin analogs, SS-288A and SS-288B, produced by a Streptomyces violaceus A262 mutant.
Saito S; Katsuda Y; Johdo O; Yoshimoto A
Biosci Biotechnol Biochem; 1995 Jan; 59(1):135-7. PubMed ID: 7765964
[TBL] [Abstract][Full Text] [Related]
11. Production of a new hybrid anthracycline 4-O-methylepelmycin by heterologous expression of dnrK in epelmycin-producing Streptomyces violaceus.
Miyamoto Y; Ohta S; Johdo O; Nagamatsu Y; Yoshimoto A
J Antibiot (Tokyo); 2000 Aug; 53(8):828-36. PubMed ID: 11079805
[TBL] [Abstract][Full Text] [Related]
12. Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant.
Yoshimoto A; Johdo O; Tone H; Okamoto R; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1992 Oct; 45(10):1609-17. PubMed ID: 1473988
[TBL] [Abstract][Full Text] [Related]
13. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. III. New anthracycline metabolites produced by blocked mutants 4L-660 and YDK-18.
Yoshimoto A; Johdo O; Nishida H; Okamoto R; Takeuchi T
J Antibiot (Tokyo); 1993 Nov; 46(11):1758-61. PubMed ID: 8270500
[No Abstract] [Full Text] [Related]
14. A new anthracycline antibiotic, IT-62-B, converts the morphology of ras-transformed cells back to normal: taxonomy, fermentation, isolation, structure elucidation and biological characterization.
Kawauchi T; Sasaki T; Yoshida K; Matsumoto H; Chen RX; Huang MY; Tsuchiya KS; Otani T
J Antibiot (Tokyo); 1997 Apr; 50(4):297-303. PubMed ID: 9186553
[TBL] [Abstract][Full Text] [Related]
15. Production of new anthracycline antibiotics by microbial 4-O-methylation using a specific daunorubicin-negative mutant.
Johdo O; Tone H; Okamoto R; Yoshimoto A; Takeuchi T
J Antibiot (Tokyo); 1992 Dec; 45(12):1837-47. PubMed ID: 1490874
[TBL] [Abstract][Full Text] [Related]
16. New anthracycline glycosides: 4-O-demethyl-11-deoxydoxorubicin and analogues from Streptomyces peucetius var. aureus.
Cassinelli G; Rivola G; Ruggieri D; Arcamone F; Grein A; Merli S; Spalla C; Casazza AM; Di Marco A; Pratesi G
J Antibiot (Tokyo); 1982 Feb; 35(2):176-83. PubMed ID: 6951826
[TBL] [Abstract][Full Text] [Related]
17. Structural studies on avidinorubicin, a novel anthracycline with platelet aggregation inhibitory activity.
Aoki M; Shirai H; Nakayama N; Itezono Y; Mori M; Satoh T; Ohshima S; Watanabe J; Yokose K; Seto H
J Antibiot (Tokyo); 1991 Jun; 44(6):635-45. PubMed ID: 2071489
[TBL] [Abstract][Full Text] [Related]
18. Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism.
Yoshimoto A; Fujii S; Johdo O; Kubo K; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Jul; 39(7):902-9. PubMed ID: 3759649
[TBL] [Abstract][Full Text] [Related]
19. A new anthracycline from endophytic Streptomyces sp. YIM66403.
Li W; Yang X; Yang Y; Zhao L; Xu L; Ding Z
J Antibiot (Tokyo); 2015 Mar; 68(3):216-9. PubMed ID: 25248729
[No Abstract] [Full Text] [Related]
20. TMC-135A and B, new triene-ansamycins, produced by Streptomyces sp.
Nishio M; Kohno J; Sakurai M; Suzuki SI; Okada N; Kawano K; Komatsubara S
J Antibiot (Tokyo); 2000 Jul; 53(7):724-7. PubMed ID: 10994816
[No Abstract] [Full Text] [Related]
[Next] [New Search]
